ETON PHARMACEUTICALS INC. - COMMON STOCK
19.81
23-5月-25 13:45:00
15 分の遅延
株式
-0.44
-2.17%
本日の幅
19.56 - 20.20
ISIN
N/A
ソース
NASDAQ
-
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
14 5 2025 13:30:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
13 5 2025 13:01:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
01 5 2025 13:30:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
28 4 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
01 4 2025 04:00:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
18 3 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
14 3 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
04 3 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
03 3 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
07 2 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
06 2 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 1 2025 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 12 2024 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 12 2024 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 12 2024 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 11 2024 03:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
12 11 2024 13:01:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
07 11 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
06 11 2024 13:30:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
03 10 2024 03:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >